

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 5.46023566 |
| 2 | L-phenylalanine catabolic process (GO:0006559) | 5.46023566 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 5.21643157 |
| 4 | L-phenylalanine metabolic process (GO:0006558) | 5.21643157 |
| 5 | complement activation, alternative pathway (GO:0006957) | 5.21473146 |
| 6 | phospholipid scrambling (GO:0017121) | 4.98547260 |
| 7 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.94423411 |
| 8 | protein carboxylation (GO:0018214) | 4.94423411 |
| 9 | aromatic amino acid family catabolic process (GO:0009074) | 4.93811033 |
| 10 | negative regulation of fibrinolysis (GO:0051918) | 4.93056569 |
| 11 | negative regulation of neurotransmitter secretion (GO:0046929) | 4.91776991 |
| 12 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.90451383 |
| 13 | regulation of protein activation cascade (GO:2000257) | 4.85711185 |
| 14 | urea cycle (GO:0000050) | 4.85589308 |
| 15 | urea metabolic process (GO:0019627) | 4.85589308 |
| 16 | alpha-linolenic acid metabolic process (GO:0036109) | 4.81888058 |
| 17 | sulfur amino acid catabolic process (GO:0000098) | 4.68698623 |
| 18 | regulation of complement activation (GO:0030449) | 4.66074830 |
| 19 | kynurenine metabolic process (GO:0070189) | 4.52932470 |
| 20 | indole-containing compound catabolic process (GO:0042436) | 4.50318643 |
| 21 | indolalkylamine catabolic process (GO:0046218) | 4.50318643 |
| 22 | tryptophan catabolic process (GO:0006569) | 4.50318643 |
| 23 | regulation of fibrinolysis (GO:0051917) | 4.46444523 |
| 24 | cysteine metabolic process (GO:0006534) | 4.45488208 |
| 25 | high-density lipoprotein particle remodeling (GO:0034375) | 4.43812341 |
| 26 | homocysteine metabolic process (GO:0050667) | 4.42907201 |
| 27 | bile acid biosynthetic process (GO:0006699) | 4.38692139 |
| 28 | tryptophan metabolic process (GO:0006568) | 4.36657164 |
| 29 | nitrogen cycle metabolic process (GO:0071941) | 4.35069244 |
| 30 | glyoxylate metabolic process (GO:0046487) | 4.18896724 |
| 31 | nuclear pore complex assembly (GO:0051292) | 4.16443380 |
| 32 | reverse cholesterol transport (GO:0043691) | 4.14138396 |
| 33 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.12798867 |
| 34 | negative regulation of cholesterol transport (GO:0032375) | 4.04017362 |
| 35 | negative regulation of sterol transport (GO:0032372) | 4.04017362 |
| 36 | hemidesmosome assembly (GO:0031581) | 3.95871767 |
| 37 | cell adhesion mediated by integrin (GO:0033627) | 3.95432013 |
| 38 | regulation of triglyceride catabolic process (GO:0010896) | 3.94821903 |
| 39 | hormone catabolic process (GO:0042447) | 3.90064875 |
| 40 | lysine catabolic process (GO:0006554) | 3.90010125 |
| 41 | lysine metabolic process (GO:0006553) | 3.90010125 |
| 42 | serine family amino acid catabolic process (GO:0009071) | 3.89991028 |
| 43 | plasma lipoprotein particle clearance (GO:0034381) | 3.89706121 |
| 44 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.85079229 |
| 45 | bile acid metabolic process (GO:0008206) | 3.81638392 |
| 46 | protein-lipid complex remodeling (GO:0034368) | 3.80025210 |
| 47 | macromolecular complex remodeling (GO:0034367) | 3.80025210 |
| 48 | plasma lipoprotein particle remodeling (GO:0034369) | 3.80025210 |
| 49 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.73290810 |
| 50 | phospholipid efflux (GO:0033700) | 3.69409574 |
| 51 | tyrosine metabolic process (GO:0006570) | 3.66920504 |
| 52 | cellular modified amino acid catabolic process (GO:0042219) | 3.66811251 |
| 53 | amino-acid betaine metabolic process (GO:0006577) | 3.56676398 |
| 54 | fibrinolysis (GO:0042730) | 3.55888594 |
| 55 | regulation of apoptotic cell clearance (GO:2000425) | 3.54446755 |
| 56 | phospholipid homeostasis (GO:0055091) | 3.53613214 |
| 57 | aromatic amino acid family metabolic process (GO:0009072) | 3.51715306 |
| 58 | regulation of membrane lipid distribution (GO:0097035) | 3.51119739 |
| 59 | regulation of cholesterol homeostasis (GO:2000188) | 3.49936704 |
| 60 | acylglycerol homeostasis (GO:0055090) | 3.48709606 |
| 61 | triglyceride homeostasis (GO:0070328) | 3.48709606 |
| 62 | complement activation (GO:0006956) | 3.48568155 |
| 63 | bile acid and bile salt transport (GO:0015721) | 3.48116588 |
| 64 | cholesterol efflux (GO:0033344) | 3.48001906 |
| 65 | valine metabolic process (GO:0006573) | 3.45849832 |
| 66 | positive regulation of lipid catabolic process (GO:0050996) | 3.44407545 |
| 67 | embryonic process involved in female pregnancy (GO:0060136) | 3.42213295 |
| 68 | alpha-amino acid catabolic process (GO:1901606) | 3.40716009 |
| 69 | cellular glucuronidation (GO:0052695) | 3.39488888 |
| 70 | nuclear pore organization (GO:0006999) | 3.38859408 |
| 71 | ethanol oxidation (GO:0006069) | 3.38470203 |
| 72 | peptide catabolic process (GO:0043171) | 3.37962973 |
| 73 | COPII vesicle coating (GO:0048208) | 3.37741816 |
| 74 | complement activation, classical pathway (GO:0006958) | 3.37431341 |
| 75 | lipid translocation (GO:0034204) | 3.35423973 |
| 76 | phospholipid translocation (GO:0045332) | 3.35423973 |
| 77 | regulation of fatty acid beta-oxidation (GO:0031998) | 3.34388762 |
| 78 | lipoprotein metabolic process (GO:0042157) | 3.33742520 |
| 79 | endodermal cell differentiation (GO:0035987) | 3.31781887 |
| 80 | regulation of cholesterol esterification (GO:0010872) | 3.30845551 |
| 81 | plasma lipoprotein particle assembly (GO:0034377) | 3.30592737 |
| 82 | epoxygenase P450 pathway (GO:0019373) | 3.29668178 |
| 83 | glycine metabolic process (GO:0006544) | 3.29231167 |
| 84 | protein activation cascade (GO:0072376) | 3.21928929 |
| 85 | protein-lipid complex assembly (GO:0065005) | 3.21602765 |
| 86 | low-density lipoprotein particle clearance (GO:0034383) | 3.21438492 |
| 87 | negative regulation of digestive system process (GO:0060457) | 3.21000030 |
| 88 | cell-substrate junction assembly (GO:0007044) | 3.20549566 |
| 89 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.20086667 |
| 90 | cellular amino acid catabolic process (GO:0009063) | 3.19530670 |
| 91 | pathway-restricted SMAD protein phosphorylation (GO:0060389) | 3.19343786 |
| 92 | apoptotic cell clearance (GO:0043277) | 3.15880992 |
| 93 | serine family amino acid metabolic process (GO:0009069) | 3.14264870 |
| 94 | 2-oxoglutarate metabolic process (GO:0006103) | 3.13914919 |
| 95 | glutamate metabolic process (GO:0006536) | 3.13695012 |
| 96 | indolalkylamine metabolic process (GO:0006586) | 3.12249779 |
| 97 | benzene-containing compound metabolic process (GO:0042537) | 3.12170903 |
| 98 | intestinal cholesterol absorption (GO:0030299) | 3.11522139 |
| 99 | sterol homeostasis (GO:0055092) | 3.11179989 |
| 100 | cholesterol homeostasis (GO:0042632) | 3.10828997 |
| 101 | acute-phase response (GO:0006953) | 3.10444327 |
| 102 | mesodermal cell differentiation (GO:0048333) | 3.08758312 |
| 103 | positive regulation of hemostasis (GO:1900048) | 3.07653603 |
| 104 | positive regulation of blood coagulation (GO:0030194) | 3.07653603 |
| 105 | skin morphogenesis (GO:0043589) | 3.06542644 |
| 106 | regulation of plasminogen activation (GO:0010755) | 3.06228814 |
| 107 | coenzyme catabolic process (GO:0009109) | 3.05349587 |
| 108 | hypotonic response (GO:0006971) | 3.04833442 |
| 109 | opsonization (GO:0008228) | 3.04764113 |
| 110 | plasma lipoprotein particle organization (GO:0071827) | 3.03203449 |
| 111 | regulation of low-density lipoprotein particle receptor biosynthetic process (GO:0045714) | 3.03122812 |
| 112 | intestinal epithelial cell development (GO:0060576) | 3.01618120 |
| 113 | protein-lipid complex subunit organization (GO:0071825) | 2.99750516 |
| 114 | negative regulation of protein activation cascade (GO:2000258) | 2.99025318 |
| 115 | uronic acid metabolic process (GO:0006063) | 2.95884677 |
| 116 | glucuronate metabolic process (GO:0019585) | 2.95884677 |
| 117 | positive regulation of coagulation (GO:0050820) | 2.95064633 |
| 118 | positive regulation of fatty acid oxidation (GO:0046321) | 2.93829189 |
| 119 | negative regulation of lipase activity (GO:0060192) | 2.91501283 |
| 120 | serine family amino acid biosynthetic process (GO:0009070) | 2.89828455 |
| 121 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 2.88622203 |
| 122 | negative regulation of DNA repair (GO:0045738) | 2.88066993 |
| 123 | imidazole-containing compound metabolic process (GO:0052803) | 2.86584495 |
| 124 | drug catabolic process (GO:0042737) | 2.85849075 |
| 125 | low-density lipoprotein particle remodeling (GO:0034374) | 2.84072266 |
| 126 | cytolysis (GO:0019835) | 2.83814614 |
| 127 | drinking behavior (GO:0042756) | 2.82835387 |
| 128 | chondrocyte proliferation (GO:0035988) | 2.79867643 |
| 129 | COPI coating of Golgi vesicle (GO:0048205) | 2.79826432 |
| 130 | Golgi transport vesicle coating (GO:0048200) | 2.79826432 |
| 131 | nucleotide-sugar biosynthetic process (GO:0009226) | 2.79051516 |
| 132 | pore complex assembly (GO:0046931) | 2.78625822 |
| 133 | regulation of transforming growth factor beta2 production (GO:0032909) | 2.75763207 |
| 134 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 2.74918336 |
| 135 | regulation of bile acid biosynthetic process (GO:0070857) | 2.73645071 |
| 136 | intestinal absorption (GO:0050892) | 2.72432256 |
| 137 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.70952509 |
| 138 | gap junction assembly (GO:0016264) | 2.64866464 |
| 139 | positive regulation of endothelial cell apoptotic process (GO:2000353) | 2.64785617 |
| 140 | negative regulation of protein tyrosine kinase activity (GO:0061099) | 2.63564767 |
| 141 | midgut development (GO:0007494) | 2.61366032 |
| 142 | cell-substrate adherens junction assembly (GO:0007045) | 2.61356663 |
| 143 | focal adhesion assembly (GO:0048041) | 2.61356663 |
| 144 | protein retention in ER lumen (GO:0006621) | 2.57920122 |
| 145 | paraxial mesoderm development (GO:0048339) | 2.55983006 |
| 146 | negative regulation of neurotransmitter transport (GO:0051589) | 2.53444082 |
| 147 | glomerular visceral epithelial cell development (GO:0072015) | 2.50431672 |
| 148 | anterior/posterior axis specification, embryo (GO:0008595) | 2.50139769 |
| 149 | positive regulation of osteoblast proliferation (GO:0033690) | 2.48921278 |
| 150 | regulation of transforming growth factor beta1 production (GO:0032908) | 2.48752983 |
| 151 | early endosome to late endosome transport (GO:0045022) | 2.47169378 |
| 152 | negative regulation of complement activation (GO:0045916) | 2.43720809 |
| 153 | pre-miRNA processing (GO:0031054) | 2.43579357 |
| 154 | negative regulation of fatty acid transport (GO:2000192) | 2.42859418 |
| 155 | substrate adhesion-dependent cell spreading (GO:0034446) | 2.40914843 |
| 156 | regulation of extracellular matrix disassembly (GO:0010715) | 2.39511433 |
| 157 | positive regulation of SMAD protein import into nucleus (GO:0060391) | 2.39185852 |
| 158 | negative regulation of fibroblast apoptotic process (GO:2000270) | 2.37810256 |
| 159 | embryonic retina morphogenesis in camera-type eye (GO:0060059) | 2.35910765 |
| 160 | adherens junction assembly (GO:0034333) | 2.34867150 |
| 161 | lipoprotein transport (GO:0042953) | 2.33014107 |
| 162 | regulation of osteoblast proliferation (GO:0033688) | 2.32775042 |
| 163 | desmosome organization (GO:0002934) | 2.32288252 |
| 164 | negative regulation of epidermal growth factor-activated receptor activity (GO:0007175) | 2.31411995 |
| 165 | negative regulation of protein localization to plasma membrane (GO:1903077) | 2.31067856 |
| 166 | negative regulation of lipid transport (GO:0032369) | 2.29914838 |
| 167 | vesicle coating (GO:0006901) | 2.29695350 |
| 168 | positive regulation of catecholamine secretion (GO:0033605) | 2.26557522 |
| 169 | regulation of transforming growth factor beta production (GO:0071634) | 2.25369272 |
| 170 | negative regulation of keratinocyte proliferation (GO:0010839) | 2.25112493 |
| 171 | negative regulation of activin receptor signaling pathway (GO:0032926) | 2.24008698 |
| 172 | positive regulation of transcription from RNA polymerase III promoter (GO:0045945) | 2.22986152 |
| 173 | negative regulation of anoikis (GO:2000811) | 2.22973369 |
| 174 | ribosome assembly (GO:0042255) | 2.21192340 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 8.66003504 |
| 2 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 6.18006094 |
| 3 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 5.48339110 |
| 4 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 5.08691472 |
| 5 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 4.51875030 |
| 6 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.86691612 |
| 7 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 3.51402359 |
| 8 | * NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.30627313 |
| 9 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 3.15050089 |
| 10 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.83378650 |
| 11 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.66485628 |
| 12 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.65457758 |
| 13 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.63242433 |
| 14 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.49364109 |
| 15 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.33499330 |
| 16 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.27011670 |
| 17 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.07703083 |
| 18 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 2.06299593 |
| 19 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.03519053 |
| 20 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.00615560 |
| 21 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 1.97600925 |
| 22 | * TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.90764595 |
| 23 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.88740406 |
| 24 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.85561407 |
| 25 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.83257123 |
| 26 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.79642087 |
| 27 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.76928908 |
| 28 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.70863853 |
| 29 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.70857890 |
| 30 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.70799824 |
| 31 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.69486188 |
| 32 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.68315182 |
| 33 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.67621966 |
| 34 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.66577853 |
| 35 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.65871254 |
| 36 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.64920033 |
| 37 | GATA1_22025678_ChIP-Seq_K562_Human | 1.63996371 |
| 38 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.63945729 |
| 39 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.61466602 |
| 40 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.57693036 |
| 41 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.57419643 |
| 42 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.55905094 |
| 43 | * SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.52923535 |
| 44 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.52618938 |
| 45 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.51075738 |
| 46 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.46719898 |
| 47 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.44674654 |
| 48 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.43726222 |
| 49 | EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 1.41349355 |
| 50 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.39596239 |
| 51 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.33374418 |
| 52 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.31903862 |
| 53 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.31573255 |
| 54 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.29848714 |
| 55 | * TP63_23658742_ChIP-Seq_EP156T_Human | 1.29749487 |
| 56 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.28493922 |
| 57 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.28349429 |
| 58 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.28078937 |
| 59 | TP53_16413492_ChIP-PET_HCT116_Human | 1.27805813 |
| 60 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.27643819 |
| 61 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 1.27474226 |
| 62 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.26590048 |
| 63 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.24723413 |
| 64 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.21324077 |
| 65 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.19222273 |
| 66 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.15628046 |
| 67 | * WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.15267224 |
| 68 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.14296148 |
| 69 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.12699451 |
| 70 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.12109813 |
| 71 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 1.12018388 |
| 72 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 1.10265330 |
| 73 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.09627783 |
| 74 | * MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.09354108 |
| 75 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.09283408 |
| 76 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.08619372 |
| 77 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.08501071 |
| 78 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.08248169 |
| 79 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.07535282 |
| 80 | * OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.06912080 |
| 81 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.05744797 |
| 82 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.05026959 |
| 83 | * TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.04975629 |
| 84 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.04606289 |
| 85 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.03703951 |
| 86 | * NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.03681167 |
| 87 | * NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.03681167 |
| 88 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.01846800 |
| 89 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.01646843 |
| 90 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.01112802 |
| 91 | CJUN_26792858_Chip-Seq_BT549_Human | 1.00994736 |
| 92 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.00886358 |
| 93 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.00821305 |
| 94 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.00521343 |
| 95 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.99415619 |
| 96 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.99193823 |
| 97 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.98803553 |
| 98 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.98803553 |
| 99 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.98175926 |
| 100 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.98063361 |
| 101 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.97929533 |
| 102 | * BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.97813014 |
| 103 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.96823922 |
| 104 | * YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.95726522 |
| 105 | TCF3_18692474_ChIP-Seq_MESCs_Mouse | 0.95312560 |
| 106 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.94821035 |
| 107 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 0.94446508 |
| 108 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.94146814 |
| 109 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.93984600 |
| 110 | TBX3_20139965_ChIP-Seq_ESCs_Mouse | 0.93785444 |
| 111 | TBX3_20139965_ChIP-Seq_MESCs_Mouse | 0.93191932 |
| 112 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.92939282 |
| 113 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.92757774 |
| 114 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.92502097 |
| 115 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.92244134 |
| 116 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.90181463 |
| 117 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.89576677 |
| 118 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.89239507 |
| 119 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.87949671 |
| 120 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.87073530 |
| 121 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.86046733 |
| 122 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.85538210 |
| 123 | ATF3_27146783_Chip-Seq_COLON_Human | 0.84301836 |
| 124 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.82277154 |
| 125 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.80849393 |
| 126 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.80576472 |
| 127 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.80576472 |
| 128 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.79794760 |
| 129 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.78654813 |
| 130 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.77710424 |
| 131 | AR_21909140_ChIP-Seq_LNCAP_Human | 0.77483161 |
| 132 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.77396581 |
| 133 | * BRD4_25478319_ChIP-Seq_HGPS_Human | 0.77150315 |
| 134 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.76985988 |
| 135 | RUNX_20019798_ChIP-Seq_JUKART_Human | 0.76717125 |
| 136 | * STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 0.76563472 |
| 137 | * GATA2_19941826_ChIP-Seq_K562_Human | 0.76458087 |
| 138 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.75498576 |
| 139 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.74617416 |
| 140 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.73580012 |
| 141 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.72775270 |
| 142 | * GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.72364932 |
| 143 | GATA1_19941826_ChIP-Seq_K562_Human | 0.71671123 |
| 144 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.71668050 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 5.92009276 |
| 2 | MP0005360_urolithiasis | 5.48322123 |
| 3 | MP0005365_abnormal_bile_salt | 4.51672616 |
| 4 | MP0005085_abnormal_gallbladder_physiolo | 4.36305553 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 3.40552980 |
| 6 | MP0003252_abnormal_bile_duct | 3.34175736 |
| 7 | MP0003705_abnormal_hypodermis_morpholog | 3.16920431 |
| 8 | MP0003941_abnormal_skin_development | 3.03190240 |
| 9 | MP0008438_abnormal_cutaneous_collagen | 2.96195136 |
| 10 | MP0010329_abnormal_lipoprotein_level | 2.69068882 |
| 11 | MP0008057_abnormal_DNA_replication | 2.54717700 |
| 12 | MP0009840_abnormal_foam_cell | 2.44083639 |
| 13 | MP0005083_abnormal_biliary_tract | 2.33247718 |
| 14 | MP0003806_abnormal_nucleotide_metabolis | 2.33136171 |
| 15 | MP0005409_darkened_coat_color | 2.30435649 |
| 16 | MP0001666_abnormal_nutrient_absorption | 2.29356821 |
| 17 | MP0003300_gastrointestinal_ulcer | 2.20380417 |
| 18 | MP0002877_abnormal_melanocyte_morpholog | 2.11195468 |
| 19 | MP0003191_abnormal_cellular_cholesterol | 2.05206932 |
| 20 | MP0005332_abnormal_amino_acid | 2.01778703 |
| 21 | MP0003950_abnormal_plasma_membrane | 2.01718360 |
| 22 | MP0003195_calcinosis | 1.93850589 |
| 23 | * MP0000609_abnormal_liver_physiology | 1.83767512 |
| 24 | MP0005275_abnormal_skin_tensile | 1.82873568 |
| 25 | MP0005257_abnormal_intraocular_pressure | 1.78820648 |
| 26 | MP0002138_abnormal_hepatobiliary_system | 1.73062293 |
| 27 | MP0010234_abnormal_vibrissa_follicle | 1.72119063 |
| 28 | MP0002009_preneoplasia | 1.65315260 |
| 29 | MP0003868_abnormal_feces_composition | 1.53267029 |
| 30 | MP0002118_abnormal_lipid_homeostasis | 1.51852276 |
| 31 | MP0005319_abnormal_enzyme/_coenzyme | 1.50972112 |
| 32 | MP0002166_altered_tumor_susceptibility | 1.45032878 |
| 33 | MP0004019_abnormal_vitamin_homeostasis | 1.41547177 |
| 34 | MP0010352_gastrointestinal_tract_polyps | 1.41168174 |
| 35 | MP0003566_abnormal_cell_adhesion | 1.30888392 |
| 36 | MP0005023_abnormal_wound_healing | 1.30549967 |
| 37 | MP0003890_abnormal_embryonic-extraembry | 1.29908422 |
| 38 | MP0000428_abnormal_craniofacial_morphol | 1.29791603 |
| 39 | MP0000762_abnormal_tongue_morphology | 1.28750761 |
| 40 | MP0010678_abnormal_skin_adnexa | 1.26512907 |
| 41 | MP0001849_ear_inflammation | 1.26263162 |
| 42 | * MP0002396_abnormal_hematopoietic_system | 1.25850235 |
| 43 | MP0002086_abnormal_extraembryonic_tissu | 1.22198012 |
| 44 | MP0006054_spinal_hemorrhage | 1.22104111 |
| 45 | * MP0009643_abnormal_urine_homeostasis | 1.19659412 |
| 46 | MP0002254_reproductive_system_inflammat | 1.19587412 |
| 47 | MP0009764_decreased_sensitivity_to | 1.19014732 |
| 48 | MP0005058_abnormal_lysosome_morphology | 1.18369987 |
| 49 | MP0004957_abnormal_blastocyst_morpholog | 1.17864971 |
| 50 | MP0004782_abnormal_surfactant_physiolog | 1.17508649 |
| 51 | MP0010368_abnormal_lymphatic_system | 1.17446156 |
| 52 | MP0002060_abnormal_skin_morphology | 1.15717458 |
| 53 | * MP0000598_abnormal_liver_morphology | 1.15463291 |
| 54 | MP0003436_decreased_susceptibility_to | 1.15392401 |
| 55 | MP0000678_abnormal_parathyroid_gland | 1.13190849 |
| 56 | MP0005647_abnormal_sex_gland | 1.11819256 |
| 57 | MP0009384_cardiac_valve_regurgitation | 1.09014885 |
| 58 | MP0009780_abnormal_chondrocyte_physiolo | 1.08242016 |
| 59 | MP0005220_abnormal_exocrine_pancreas | 1.06874214 |
| 60 | MP0000920_abnormal_myelination | 1.05334838 |
| 61 | MP0004947_skin_inflammation | 1.04629357 |
| 62 | MP0002089_abnormal_postnatal_growth/wei | 1.04073480 |
| 63 | MP0000462_abnormal_digestive_system | 1.01631842 |
| 64 | MP0008961_abnormal_basal_metabolism | 1.01036601 |
| 65 | MP0000013_abnormal_adipose_tissue | 1.00540596 |
| 66 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.00466454 |
| 67 | MP0000432_abnormal_head_morphology | 0.99634619 |
| 68 | MP0000383_abnormal_hair_follicle | 0.98873760 |
| 69 | MP0003828_pulmonary_edema | 0.98366458 |
| 70 | MP0009763_increased_sensitivity_to | 0.96897475 |
| 71 | MP0003329_amyloid_beta_deposits | 0.96531334 |
| 72 | MP0004272_abnormal_basement_membrane | 0.95916827 |
| 73 | MP0005621_abnormal_cell_physiology | 0.95870940 |
| 74 | MP0005076_abnormal_cell_differentiation | 0.95641621 |
| 75 | MP0009053_abnormal_anal_canal | 0.95025518 |
| 76 | MP0005503_abnormal_tendon_morphology | 0.94738398 |
| 77 | MP0005408_hypopigmentation | 0.94702852 |
| 78 | MP0005670_abnormal_white_adipose | 0.93979858 |
| 79 | MP0003984_embryonic_growth_retardation | 0.93452840 |
| 80 | MP0001730_embryonic_growth_arrest | 0.93324086 |
| 81 | MP0001299_abnormal_eye_distance/ | 0.92863190 |
| 82 | MP0002088_abnormal_embryonic_growth/wei | 0.92516492 |
| 83 | MP0002006_tumorigenesis | 0.92167733 |
| 84 | MP0008469_abnormal_protein_level | 0.91527191 |
| 85 | MP0005464_abnormal_platelet_physiology | 0.90750565 |
| 86 | MP0003279_aneurysm | 0.90721696 |
| 87 | MP0004233_abnormal_muscle_weight | 0.89972306 |
| 88 | MP0000604_amyloidosis | 0.89927044 |
| 89 | MP0002168_other_aberrant_phenotype | 0.88590020 |
| 90 | MP0005380_embryogenesis_phenotype | 0.87820382 |
| 91 | MP0001672_abnormal_embryogenesis/_devel | 0.87820382 |
| 92 | MP0002084_abnormal_developmental_patter | 0.87538661 |
| 93 | MP0004130_abnormal_muscle_cell | 0.86957845 |
| 94 | MP0003690_abnormal_glial_cell | 0.86502049 |
| 95 | MP0003448_altered_tumor_morphology | 0.86245321 |
| 96 | MP0004264_abnormal_extraembryonic_tissu | 0.85998931 |
| 97 | MP0001756_abnormal_urination | 0.85957211 |
| 98 | MP0003186_abnormal_redox_activity | 0.85756328 |
| 99 | MP0003453_abnormal_keratinocyte_physiol | 0.85388906 |
| 100 | MP0003091_abnormal_cell_migration | 0.84681875 |
| 101 | MP0000627_abnormal_mammary_gland | 0.84668425 |
| 102 | MP0001216_abnormal_epidermal_layer | 0.84619906 |
| 103 | MP0009672_abnormal_birth_weight | 0.83798710 |
| 104 | MP0001958_emphysema | 0.83523406 |
| 105 | MP0003303_peritoneal_inflammation | 0.83492670 |
| 106 | MP0002998_abnormal_bone_remodeling | 0.82594359 |
| 107 | MP0003935_abnormal_craniofacial_develop | 0.82500066 |
| 108 | MP0001533_abnormal_skeleton_physiology | 0.82134008 |
| 109 | MP0000490_abnormal_crypts_of | 0.81855537 |
| 110 | MP0004134_abnormal_chest_morphology | 0.81170303 |
| 111 | MP0010307_abnormal_tumor_latency | 0.81033488 |
| 112 | MP0008007_abnormal_cellular_replicative | 0.80030317 |
| 113 | MP0002925_abnormal_cardiovascular_devel | 0.79442984 |
| 114 | MP0001764_abnormal_homeostasis | 0.78210307 |
| 115 | MP0005623_abnormal_meninges_morphology | 0.77846339 |
| 116 | MP0005666_abnormal_adipose_tissue | 0.77722405 |
| 117 | * MP0002136_abnormal_kidney_physiology | 0.77552001 |
| 118 | MP0003724_increased_susceptibility_to | 0.77178832 |
| 119 | MP0003045_fibrosis | 0.76369306 |
| 120 | MP0001243_abnormal_dermal_layer | 0.76348401 |
| 121 | MP0000767_abnormal_smooth_muscle | 0.76140547 |
| 122 | MP0003632_abnormal_nervous_system | 0.75661168 |
| 123 | MP0001614_abnormal_blood_vessel | 0.75460054 |
| 124 | MP0008004_abnormal_stomach_pH | 0.75303740 |
| 125 | MP0000579_abnormal_nail_morphology | 0.74162424 |
| 126 | MP0003115_abnormal_respiratory_system | 0.73612567 |
| 127 | MP0003183_abnormal_peptide_metabolism | 0.72878845 |
| 128 | MP0004185_abnormal_adipocyte_glucose | 0.72078601 |
| 129 | MP0000477_abnormal_intestine_morphology | 0.72036561 |
| 130 | MP0002928_abnormal_bile_duct | 0.71324768 |
| 131 | MP0002295_abnormal_pulmonary_circulatio | 0.70863488 |
| 132 | MP0005451_abnormal_body_composition | 0.69107819 |
| 133 | MP0002896_abnormal_bone_mineralization | 0.68065527 |
| 134 | MP0001915_intracranial_hemorrhage | 0.68019573 |
| 135 | * MP0001845_abnormal_inflammatory_respons | 0.67504633 |
| 136 | MP0009642_abnormal_blood_homeostasis | 0.67497541 |
| 137 | MP0005636_abnormal_mineral_homeostasis | 0.67288267 |
| 138 | MP0000685_abnormal_immune_system | 0.67272149 |
| 139 | MP0009697_abnormal_copulation | 0.67171860 |
| 140 | MP0005334_abnormal_fat_pad | 0.66652178 |
| 141 | MP0001661_extended_life_span | 0.64003554 |
| 142 | MP0009765_abnormal_xenobiotic_induced | 0.63360307 |
| 143 | MP0005164_abnormal_response_to | 0.62445224 |
| 144 | MP0010155_abnormal_intestine_physiology | 0.62231259 |
| 145 | MP0000249_abnormal_blood_vessel | 0.61787604 |
| 146 | MP0002971_abnormal_brown_adipose | 0.60583248 |
| 147 | MP0001881_abnormal_mammary_gland | 0.59864726 |
| 148 | MP0001873_stomach_inflammation | 0.59199905 |
| 149 | MP0002419_abnormal_innate_immunity | 0.58290016 |
| 150 | MP0005166_decreased_susceptibility_to | 0.56349671 |
| 151 | * MP0002135_abnormal_kidney_morphology | 0.56219974 |
| 152 | MP0002796_impaired_skin_barrier | 0.53924680 |
| 153 | MP0003075_altered_response_to | 0.52807388 |
| 154 | MP0001835_abnormal_antigen_presentation | 0.51599097 |
| 155 | MP0002128_abnormal_blood_circulation | 0.51323074 |
| 156 | MP0009115_abnormal_fat_cell | 0.51119024 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Deep venous thrombosis (HP:0002625) | 6.29033268 |
| 2 | Intrahepatic cholestasis (HP:0001406) | 5.21458828 |
| 3 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 5.01312211 |
| 4 | Xanthomatosis (HP:0000991) | 4.98960496 |
| 5 | Complement deficiency (HP:0004431) | 4.97274491 |
| 6 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 4.63094108 |
| 7 | Prolonged partial thromboplastin time (HP:0003645) | 4.57124580 |
| 8 | Hypobetalipoproteinemia (HP:0003563) | 4.38399685 |
| 9 | Abnormality of the common coagulation pathway (HP:0010990) | 4.36041781 |
| 10 | Abnormality of complement system (HP:0005339) | 3.91589898 |
| 11 | Hyperlipoproteinemia (HP:0010980) | 3.72282841 |
| 12 | Myocardial infarction (HP:0001658) | 3.68572698 |
| 13 | Joint hemorrhage (HP:0005261) | 3.66814529 |
| 14 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.58923217 |
| 15 | Hypolipoproteinemia (HP:0010981) | 3.58439792 |
| 16 | Epidermoid cyst (HP:0200040) | 3.55770508 |
| 17 | Abnormality of the intrinsic pathway (HP:0010989) | 3.43173821 |
| 18 | Flat acetabular roof (HP:0003180) | 3.40731664 |
| 19 | Hypoalphalipoproteinemia (HP:0003233) | 3.40570319 |
| 20 | Systemic lupus erythematosus (HP:0002725) | 3.36526185 |
| 21 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.32209763 |
| 22 | Arterial tortuosity (HP:0005116) | 3.31103026 |
| 23 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.29477975 |
| 24 | Fat malabsorption (HP:0002630) | 3.16869436 |
| 25 | Vascular tortuosity (HP:0004948) | 3.11025093 |
| 26 | Hyperammonemia (HP:0001987) | 3.11017507 |
| 27 | Papillary thyroid carcinoma (HP:0002895) | 2.95068176 |
| 28 | Ketosis (HP:0001946) | 2.94943414 |
| 29 | Atrophic scars (HP:0001075) | 2.92611238 |
| 30 | Protrusio acetabuli (HP:0003179) | 2.92203947 |
| 31 | Ankyloglossia (HP:0010296) | 2.91198930 |
| 32 | Peritonitis (HP:0002586) | 2.89964460 |
| 33 | Esophageal varix (HP:0002040) | 2.81900509 |
| 34 | Mitral stenosis (HP:0001718) | 2.77492994 |
| 35 | Glomerulonephritis (HP:0000099) | 2.76480148 |
| 36 | Hypercholesterolemia (HP:0003124) | 2.76476428 |
| 37 | Hypoglycemic coma (HP:0001325) | 2.72990463 |
| 38 | Hepatocellular carcinoma (HP:0001402) | 2.70741982 |
| 39 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.70396501 |
| 40 | Skin nodule (HP:0200036) | 2.65322225 |
| 41 | Hyperglycinuria (HP:0003108) | 2.61862336 |
| 42 | Abnormality of methionine metabolism (HP:0010901) | 2.61016382 |
| 43 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.58997032 |
| 44 | Hyperglycinemia (HP:0002154) | 2.56859395 |
| 45 | Subacute progressive viral hepatitis (HP:0006572) | 2.56624230 |
| 46 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.55790194 |
| 47 | Abnormality of glycine metabolism (HP:0010895) | 2.55790194 |
| 48 | Abnormality of oral frenula (HP:0000190) | 2.50777442 |
| 49 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.50712501 |
| 50 | Nephritis (HP:0000123) | 2.50644008 |
| 51 | Conjugated hyperbilirubinemia (HP:0002908) | 2.48548242 |
| 52 | Abnormal foot bone ossification (HP:0010675) | 2.47011296 |
| 53 | Spastic diplegia (HP:0001264) | 2.45782286 |
| 54 | Menorrhagia (HP:0000132) | 2.43122986 |
| 55 | Premature rupture of membranes (HP:0001788) | 2.39580160 |
| 56 | Abnormality of carpal bone ossification (HP:0006257) | 2.39193066 |
| 57 | Scanning speech (HP:0002168) | 2.37441500 |
| 58 | Aortic aneurysm (HP:0004942) | 2.35190914 |
| 59 | Wormian bones (HP:0002645) | 2.34560917 |
| 60 | Abnormality of nucleobase metabolism (HP:0010932) | 2.34197385 |
| 61 | Vertebral arch anomaly (HP:0008438) | 2.31165587 |
| 62 | Cardiovascular calcification (HP:0011915) | 2.29711993 |
| 63 | Steatorrhea (HP:0002570) | 2.29575791 |
| 64 | Relative macrocephaly (HP:0004482) | 2.29294023 |
| 65 | Vertebral compression fractures (HP:0002953) | 2.28648163 |
| 66 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.26793479 |
| 67 | Osteolytic defects of the hand bones (HP:0009699) | 2.26793479 |
| 68 | Abnormality of purine metabolism (HP:0004352) | 2.25939828 |
| 69 | Cerebral aneurysm (HP:0004944) | 2.25547552 |
| 70 | Hemorrhage of the eye (HP:0011885) | 2.23014979 |
| 71 | Aortic dissection (HP:0002647) | 2.21827084 |
| 72 | Mitral valve prolapse (HP:0001634) | 2.21281321 |
| 73 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.20197761 |
| 74 | Asymmetry of the thorax (HP:0001555) | 2.19890493 |
| 75 | Increased mean platelet volume (HP:0011877) | 2.17963800 |
| 76 | Spinal cord lesions (HP:0100561) | 2.15218192 |
| 77 | Syringomyelia (HP:0003396) | 2.15218192 |
| 78 | Spontaneous abortion (HP:0005268) | 2.14232645 |
| 79 | Hydroxyprolinuria (HP:0003080) | 2.13756576 |
| 80 | Abnormality of proline metabolism (HP:0010907) | 2.13756576 |
| 81 | Vascular calcification (HP:0004934) | 2.12831372 |
| 82 | Abnormality of the acetabulum (HP:0003170) | 2.12363969 |
| 83 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.12194718 |
| 84 | Abnormal ossification of hand bones (HP:0005921) | 2.09934935 |
| 85 | Gingival bleeding (HP:0000225) | 2.09817553 |
| 86 | Ketoacidosis (HP:0001993) | 2.09086254 |
| 87 | Cervical subluxation (HP:0003308) | 2.07493036 |
| 88 | Aplasia/Hypoplasia of the vertebrae (HP:0008515) | 2.07098375 |
| 89 | Vertebral hypoplasia (HP:0008417) | 2.07098375 |
| 90 | Dilatation of the ascending aorta (HP:0005111) | 2.03267844 |
| 91 | Absent frontal sinuses (HP:0002688) | 2.00358940 |
| 92 | Abnormal tarsal ossification (HP:0008369) | 1.99607534 |
| 93 | Aneurysm (HP:0002617) | 1.98267268 |
| 94 | Hypophosphatemic rickets (HP:0004912) | 1.97079587 |
| 95 | Abnormal platelet volume (HP:0011876) | 1.95584223 |
| 96 | Acanthocytosis (HP:0001927) | 1.95216273 |
| 97 | Hyperbilirubinemia (HP:0002904) | 1.94974234 |
| 98 | Abnormal cartilage morphology (HP:0002763) | 1.94654442 |
| 99 | Broad metatarsal (HP:0001783) | 1.93895611 |
| 100 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.93767074 |
| 101 | Mucopolysacchariduria (HP:0008155) | 1.93767074 |
| 102 | Fragile skin (HP:0001030) | 1.93094480 |
| 103 | Back pain (HP:0003418) | 1.89785299 |
| 104 | Thrombophlebitis (HP:0004418) | 1.88183897 |
| 105 | Cone-shaped epiphyses of the phalanges of the hand (HP:0010230) | 1.87312657 |
| 106 | Ectopia lentis (HP:0001083) | 1.86922269 |
| 107 | Spinal rigidity (HP:0003306) | 1.86801074 |
| 108 | Selective tooth agenesis (HP:0001592) | 1.86164855 |
| 109 | Ankle contracture (HP:0006466) | 1.85983421 |
| 110 | Abnormality of the lumbar spine (HP:0100712) | 1.85946423 |
| 111 | Coronal craniosynostosis (HP:0004440) | 1.84804026 |
| 112 | Abnormal delivery (HP:0001787) | 1.84731228 |
| 113 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.84054192 |
| 114 | Shallow orbits (HP:0000586) | 1.83388034 |
| 115 | Hematochezia (HP:0002573) | 1.82723001 |
| 116 | Cupped ribs (HP:0000887) | 1.82191096 |
| 117 | Abnormal hand bone ossification (HP:0010660) | 1.81936283 |
| 118 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.81442394 |
| 119 | Lymphangioma (HP:0100764) | 1.81394704 |
| 120 | Amyloidosis (HP:0011034) | 1.81054119 |
| 121 | Spondylolisthesis (HP:0003302) | 1.81003056 |
| 122 | Neonatal short-limb short stature (HP:0008921) | 1.80729228 |
| 123 | Delayed closure of the anterior fontanelle (HP:0001476) | 1.80435220 |
| 124 | Missing ribs (HP:0000921) | 1.78675086 |
| 125 | Overgrowth (HP:0001548) | 1.77294009 |
| 126 | Hypochromic microcytic anemia (HP:0004840) | 1.76074140 |
| 127 | Ulnar bowing (HP:0003031) | 1.75696455 |
| 128 | Tetraparesis (HP:0002273) | 1.75648639 |
| 129 | Blue sclerae (HP:0000592) | 1.75222629 |
| 130 | Pancreatitis (HP:0001733) | 1.73528174 |
| 131 | Abnormality of the Achilles tendon (HP:0005109) | 1.73509140 |
| 132 | Stroke (HP:0001297) | 1.72743915 |
| 133 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.72671291 |
| 134 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.72671291 |
| 135 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.72671291 |
| 136 | Conjunctival telangiectasia (HP:0000524) | 1.72648070 |
| 137 | Sensorimotor neuropathy (HP:0007141) | 1.71813402 |
| 138 | Turricephaly (HP:0000262) | 1.71587796 |
| 139 | Abnormality of iron homeostasis (HP:0011031) | 1.69673368 |
| 140 | Hereditary nonpolyposis colorectal carcinoma (HP:0006716) | 1.68947872 |
| 141 | Alopecia of scalp (HP:0002293) | 1.68804687 |
| 142 | Coxa vara (HP:0002812) | 1.68003289 |
| 143 | Malnutrition (HP:0004395) | 1.67981610 |
| 144 | Right ventricular cardiomyopathy (HP:0011663) | 1.67448898 |
| 145 | Vacuolated lymphocytes (HP:0001922) | 1.66882407 |
| 146 | Soft skin (HP:0000977) | 1.66424157 |
| 147 | Hypoglycemic seizures (HP:0002173) | 1.65437349 |
| 148 | Thickened calvaria (HP:0002684) | 1.64581093 |
| 149 | Thoracolumbar scoliosis (HP:0002944) | 1.63558934 |
| 150 | Abnormality of the distal phalanx of the thumb (HP:0009617) | 1.63335544 |
| 151 | Abnormality of dentin (HP:0010299) | 1.62490054 |
| 152 | Rickets (HP:0002748) | 1.59706442 |
| 153 | Thyroid carcinoma (HP:0002890) | 1.59493011 |
| 154 | Advanced eruption of teeth (HP:0006288) | 1.58082046 |
| 155 | Fused cervical vertebrae (HP:0002949) | 1.57554011 |
| 156 | Joint laxity (HP:0001388) | 1.57417723 |
| 157 | Biconcave vertebral bodies (HP:0004586) | 1.57205436 |
| 158 | Malignant gastrointestinal tract tumors (HP:0006749) | 1.56645455 |
| 159 | Gastrointestinal carcinoma (HP:0002672) | 1.56645455 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ERN1 | 4.39545704 |
| 2 | EIF2AK3 | 3.46181740 |
| 3 | SIK1 | 3.45406803 |
| 4 | TRIB3 | 3.30483040 |
| 5 | LATS1 | 3.21524291 |
| 6 | FRK | 3.01485709 |
| 7 | PKN2 | 2.79328885 |
| 8 | TAOK3 | 2.76279609 |
| 9 | FGFR4 | 2.59709822 |
| 10 | BCKDK | 2.53737986 |
| 11 | MST1R | 2.29038716 |
| 12 | PRKG2 | 2.27466020 |
| 13 | TTN | 2.18317359 |
| 14 | PTK6 | 2.13769895 |
| 15 | RIPK1 | 1.97655744 |
| 16 | MAP3K10 | 1.83251235 |
| 17 | EEF2K | 1.78948417 |
| 18 | PBK | 1.78513290 |
| 19 | TYK2 | 1.68439313 |
| 20 | CAMK1D | 1.67719864 |
| 21 | PDGFRA | 1.65412996 |
| 22 | PRPF4B | 1.54892890 |
| 23 | BRSK2 | 1.53984536 |
| 24 | JAK1 | 1.50708022 |
| 25 | STK3 | 1.45547495 |
| 26 | TGFBR2 | 1.42904213 |
| 27 | INSRR | 1.40446564 |
| 28 | LRRK2 | 1.38477236 |
| 29 | NEK9 | 1.35101752 |
| 30 | EPHB1 | 1.34264311 |
| 31 | STK10 | 1.31055264 |
| 32 | FGFR3 | 1.29382452 |
| 33 | BMX | 1.26624890 |
| 34 | SCYL2 | 1.24369907 |
| 35 | FLT3 | 1.24248253 |
| 36 | ICK | 1.22055833 |
| 37 | MET | 1.21842601 |
| 38 | WNK1 | 1.19969151 |
| 39 | NTRK1 | 1.17357758 |
| 40 | CDK12 | 1.16449308 |
| 41 | CDK6 | 1.15748724 |
| 42 | DDR2 | 1.15722071 |
| 43 | FGFR2 | 1.15015226 |
| 44 | CAMK1G | 1.09313538 |
| 45 | STK38 | 1.09001419 |
| 46 | PIK3CG | 1.08976705 |
| 47 | STK38L | 1.07322706 |
| 48 | JAK3 | 1.06279872 |
| 49 | EPHA3 | 1.03067466 |
| 50 | TTK | 1.02880106 |
| 51 | MAP2K3 | 1.02832315 |
| 52 | LMTK2 | 1.02743405 |
| 53 | TBK1 | 1.01805517 |
| 54 | STK24 | 1.01261568 |
| 55 | YES1 | 0.99318858 |
| 56 | BRD4 | 0.99000051 |
| 57 | CSK | 0.97128928 |
| 58 | ERBB4 | 0.96046092 |
| 59 | JAK2 | 0.95755926 |
| 60 | MAP3K3 | 0.93672681 |
| 61 | PTK2 | 0.92643321 |
| 62 | NUAK1 | 0.91428333 |
| 63 | EPHA2 | 0.91250815 |
| 64 | KSR2 | 0.91162162 |
| 65 | MTOR | 0.91066470 |
| 66 | TRPM7 | 0.90893396 |
| 67 | STK39 | 0.90661542 |
| 68 | MAP3K14 | 0.90429704 |
| 69 | PAK2 | 0.85359906 |
| 70 | CSF1R | 0.83310253 |
| 71 | MAP3K7 | 0.83263616 |
| 72 | NLK | 0.81019101 |
| 73 | PDGFRB | 0.79870694 |
| 74 | SGK2 | 0.77565923 |
| 75 | MAPK11 | 0.77157579 |
| 76 | AKT3 | 0.75461683 |
| 77 | FER | 0.73182479 |
| 78 | SMG1 | 0.71406202 |
| 79 | MAP3K2 | 0.71307673 |
| 80 | EIF2AK2 | 0.69630005 |
| 81 | MAP3K1 | 0.69432467 |
| 82 | MAP4K1 | 0.68377758 |
| 83 | MYLK | 0.67886978 |
| 84 | GRK6 | 0.64252112 |
| 85 | KDR | 0.61505893 |
| 86 | RET | 0.59950281 |
| 87 | GSK3A | 0.57460154 |
| 88 | RPS6KB2 | 0.57417773 |
| 89 | FGFR1 | 0.57313599 |
| 90 | PRKAA2 | 0.57274104 |
| 91 | ZAP70 | 0.55265501 |
| 92 | CHUK | 0.54918071 |
| 93 | NEK6 | 0.52812285 |
| 94 | EGFR | 0.52502870 |
| 95 | RPS6KB1 | 0.52056819 |
| 96 | RPS6KA4 | 0.52012255 |
| 97 | CDK4 | 0.51685069 |
| 98 | PRKD2 | 0.51211330 |
| 99 | DYRK1B | 0.50248942 |
| 100 | ACVR1B | 0.49122588 |
| 101 | SGK3 | 0.47654053 |
| 102 | ERBB2 | 0.47106701 |
| 103 | MELK | 0.44989619 |
| 104 | DMPK | 0.44493008 |
| 105 | ERBB3 | 0.44170698 |
| 106 | ITK | 0.43659278 |
| 107 | IGF1R | 0.43065183 |
| 108 | TEC | 0.42885896 |
| 109 | PIK3CA | 0.41703477 |
| 110 | MAP2K1 | 0.41119481 |
| 111 | IKBKE | 0.40723480 |
| 112 | PRKCH | 0.40719608 |
| 113 | IRAK3 | 0.40175285 |
| 114 | MAP3K8 | 0.39955883 |
| 115 | PAK4 | 0.39734601 |
| 116 | ABL2 | 0.38719555 |
| 117 | LATS2 | 0.38719181 |
| 118 | TAF1 | 0.38297313 |
| 119 | SGK223 | 0.37246207 |
| 120 | SGK494 | 0.37246207 |
| 121 | HCK | 0.36090153 |
| 122 | ABL1 | 0.36009220 |
| 123 | INSR | 0.35742097 |
| 124 | MAPK7 | 0.35397184 |
| 125 | ALK | 0.34878126 |
| 126 | PDPK1 | 0.34547875 |
| 127 | TGFBR1 | 0.34389470 |
| 128 | IKBKB | 0.31681496 |
| 129 | KIT | 0.31645194 |
| 130 | PIM1 | 0.30446629 |
| 131 | EPHB2 | 0.30373738 |
| 132 | ROCK2 | 0.30232415 |
| 133 | MAP3K12 | 0.29634311 |
| 134 | MAP3K6 | 0.29501326 |
| 135 | STK4 | 0.29415429 |
| 136 | MST4 | 0.28868241 |
| 137 | CDK9 | 0.28504842 |
| 138 | BTK | 0.27493999 |
| 139 | PRKCQ | 0.26646626 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.96113326 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.77226903 |
| 3 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.30236635 |
| 4 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 3.09427256 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.99200887 |
| 6 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.96637825 |
| 7 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.51006406 |
| 8 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.44457802 |
| 9 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.38328822 |
| 10 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.25355734 |
| 11 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.17164159 |
| 12 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.09602349 |
| 13 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.08716469 |
| 14 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.04568126 |
| 15 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.98883509 |
| 16 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.97570450 |
| 17 | Thyroid cancer_Homo sapiens_hsa05216 | 1.66416454 |
| 18 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.65827596 |
| 19 | Peroxisome_Homo sapiens_hsa04146 | 1.65084186 |
| 20 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.64710031 |
| 21 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.64372478 |
| 22 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.58342162 |
| 23 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.58110641 |
| 24 | Histidine metabolism_Homo sapiens_hsa00340 | 1.54622691 |
| 25 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.52352076 |
| 26 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.49331753 |
| 27 | Bile secretion_Homo sapiens_hsa04976 | 1.42793044 |
| 28 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.42336056 |
| 29 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.40276365 |
| 30 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.40099080 |
| 31 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.36625175 |
| 32 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.36532847 |
| 33 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.34346324 |
| 34 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.32011007 |
| 35 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.30580507 |
| 36 | Retinol metabolism_Homo sapiens_hsa00830 | 1.28361275 |
| 37 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.26361731 |
| 38 | ABC transporters_Homo sapiens_hsa02010 | 1.23360875 |
| 39 | Lysine degradation_Homo sapiens_hsa00310 | 1.20775686 |
| 40 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 1.19954342 |
| 41 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 1.16021316 |
| 42 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.15779791 |
| 43 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.14045496 |
| 44 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 1.12904093 |
| 45 | Endometrial cancer_Homo sapiens_hsa05213 | 1.11954237 |
| 46 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.10376578 |
| 47 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 1.09865452 |
| 48 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.07452193 |
| 49 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.03102203 |
| 50 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.99684680 |
| 51 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.97071175 |
| 52 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.95883896 |
| 53 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.93286989 |
| 54 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.92515309 |
| 55 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.91132490 |
| 56 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.87429023 |
| 57 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.86668262 |
| 58 | Carbon metabolism_Homo sapiens_hsa01200 | 0.85964492 |
| 59 | Platelet activation_Homo sapiens_hsa04611 | 0.84908253 |
| 60 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.84461749 |
| 61 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.83132454 |
| 62 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.83101316 |
| 63 | Glioma_Homo sapiens_hsa05214 | 0.82906550 |
| 64 | * N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.80061441 |
| 65 | Melanoma_Homo sapiens_hsa05218 | 0.77587798 |
| 66 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.74486412 |
| 67 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.74110552 |
| 68 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.72816494 |
| 69 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.72229767 |
| 70 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.72218214 |
| 71 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.71940226 |
| 72 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.70664364 |
| 73 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.70297710 |
| 74 | Insulin resistance_Homo sapiens_hsa04931 | 0.70128074 |
| 75 | Pathways in cancer_Homo sapiens_hsa05200 | 0.68737200 |
| 76 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.68437092 |
| 77 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.68135289 |
| 78 | Tight junction_Homo sapiens_hsa04530 | 0.67215031 |
| 79 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.67151921 |
| 80 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.66320169 |
| 81 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.65908965 |
| 82 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.65354130 |
| 83 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.63000386 |
| 84 | Gap junction_Homo sapiens_hsa04540 | 0.62562599 |
| 85 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.62274939 |
| 86 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.61116311 |
| 87 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.61069250 |
| 88 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.60597234 |
| 89 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.59806036 |
| 90 | Amoebiasis_Homo sapiens_hsa05146 | 0.59751286 |
| 91 | Renin secretion_Homo sapiens_hsa04924 | 0.58107891 |
| 92 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.56358522 |
| 93 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.54389727 |
| 94 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.53852988 |
| 95 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.53718123 |
| 96 | Colorectal cancer_Homo sapiens_hsa05210 | 0.53694807 |
| 97 | Sulfur relay system_Homo sapiens_hsa04122 | 0.53481633 |
| 98 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.53295316 |
| 99 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.53088009 |
| 100 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.52696580 |
| 101 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.50623150 |
| 102 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.50402689 |
| 103 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.50262294 |
| 104 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.49784348 |
| 105 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.48127020 |
| 106 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.47151616 |
| 107 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.46639477 |
| 108 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.46468602 |
| 109 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.46085209 |
| 110 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.45672203 |
| 111 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.45422605 |
| 112 | Prion diseases_Homo sapiens_hsa05020 | 0.44968446 |
| 113 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.44742612 |
| 114 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.44445755 |
| 115 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.42644818 |
| 116 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.41259767 |
| 117 | Focal adhesion_Homo sapiens_hsa04510 | 0.39866709 |
| 118 | Adherens junction_Homo sapiens_hsa04520 | 0.39853820 |
| 119 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.38150502 |
| 120 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.35968389 |
| 121 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.33970228 |
| 122 | Malaria_Homo sapiens_hsa05144 | 0.31758079 |
| 123 | Other glycan degradation_Homo sapiens_hsa00511 | 0.31649052 |
| 124 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.30880320 |
| 125 | Lysosome_Homo sapiens_hsa04142 | 0.29440328 |
| 126 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.29171536 |
| 127 | Bladder cancer_Homo sapiens_hsa05219 | 0.27682251 |
| 128 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.27448492 |
| 129 | Pertussis_Homo sapiens_hsa05133 | 0.26597382 |
| 130 | Hepatitis C_Homo sapiens_hsa05160 | 0.25502197 |
| 131 | Leishmaniasis_Homo sapiens_hsa05140 | 0.25076720 |
| 132 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.24041232 |
| 133 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.21335747 |
| 134 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.20672540 |
| 135 | Prostate cancer_Homo sapiens_hsa05215 | 0.20446815 |
| 136 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.19263879 |
| 137 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.18822605 |
| 138 | Legionellosis_Homo sapiens_hsa05134 | 0.18390823 |
| 139 | Galactose metabolism_Homo sapiens_hsa00052 | 0.18081549 |
| 140 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.15771403 |
| 141 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.14725476 |
| 142 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.13249231 |
| 143 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.12907379 |
| 144 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.12774805 |

